<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors provide grounds for the principles of pathogenic therapy aimed at posthemorrhagic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e>, proliferation-necrotic <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">angiopathy</z:e> with ensuing cerebral damage wherein free radical oxidation and antifibrinolytic therapy are of major importance </plain></SENT>
<SENT sid="1" pm="."><plain>The efficiency of combined pathogenic therapy comprising <z:chebi fb="11" ids="22586">antioxidants</z:chebi>, <z:chebi fb="0" ids="38161">chelators</z:chebi>, <z:chebi fb="0" ids="35544">cyclooxygenase inhibitors</z:chebi>, calcium <z:chebi fb="68" ids="48706">antagonists</z:chebi>, <z:chebi fb="8" ids="29745">barbiturate</z:chebi> protectors, membrane-stabilizing and limiting antifibrinolytic hemostatic drugs is evaluated </plain></SENT>
</text></document>